"Insulin, Isophane" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
An intermediate-acting INSULIN preparation with onset time of 2 hours and duration of 24 hours. It is produced by crystallizing ZINC-insulin-PROTAMINES at neutral pH 7. Thus it is called neutral protamine Hagedorn for inventor Hans Christian Hagedorn.
| Descriptor ID |
D007336
|
| MeSH Number(s) |
D06.472.699.587.200.300.200 D12.644.548.586.200.300.200
|
| Concept/Terms |
Insulin, Isophane- Insulin, Isophane
- Isophane Insulin
- Neutral Protamine Hagedorn Insulin
- Protamine Hagedorn Insulin
- Hagedorn Insulin, Protamine
- Isophane Insulin, Regular
- Regular Isophane Insulin
- Insulin, NPH
- NPH Insulin
|
Below are MeSH descriptors whose meaning is more general than "Insulin, Isophane".
Below are MeSH descriptors whose meaning is more specific than "Insulin, Isophane".
This graph shows the total number of publications written about "Insulin, Isophane" by people in this website by year, and whether "Insulin, Isophane" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2008 | 1 | 0 | 1 |
| 2018 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Insulin, Isophane" by people in Profiles.
-
Association of Initiation of Basal Insulin Analogs vs Neutral Protamine Hagedorn Insulin With Hypoglycemia-Related Emergency Department Visits or Hospital Admissions and With Glycemic Control in Patients With Type 2 Diabetes. JAMA. 2018 07 03; 320(1):53-62.
-
Safety and efficacy of glargine compared with NPH insulin for the treatment of Type 2 diabetes: a meta-analysis of randomized controlled trials. Diabet Med. 2008 Aug; 25(8):924-32.